Cybin Inc. (CYBN)

NYSEAMERICAN: CYBN · Real-Time Price · USD

9.61

+0.29 (3.11%)

At close: Dec 20, 2024, 4:00 PM

9.66

+0.05 (0.52%)

After-hours: Dec 20, 2024, 7:58 PM EST

Cybin Employees

Cybin had 50 employees as of March 31, 2024. The number of employees did not change compared to the previous year.

Employees

50

Change (1Y)

n/a

Growth (1Y)

n/a

Revenue / Employee

n/a

Profits / Employee

-$1,831,185

Market Cap

192.21M

Employees Chart

Employees History

Date	Employees	Change	Growth
Mar 31, 2024	50	0	-
Mar 31, 2023	50	0	-
Mar 31, 2022	50	12	31.58%
Mar 31, 2021	38	-	-

Related Stocks

Company Name	Employees
Organigram Holdings	984
ADC Therapeutics	274
Fate Therapeutics	181
Gossamer Bio	135
Inventiva	123
Mersana Therapeutics	123
Perspective Therapeutics	119
XBiotech	82

Employee Rankings

CYBN News

11 days ago - Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including CYB003 12-Month Efficacy Results - Business Wire
17 days ago - Cybin to Participate in Water Tower Research Fireside Chat on December 11, 2024 - Business Wire
4 weeks ago - Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder - Business Wire
5 weeks ago - Cybin to Present 12-Month Phase 2 Data for CYB003 in Major Depressive Disorder on November 18, 2024 - Business Wire
5 weeks ago - Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder and Reports Second Quarter Financial Results - Business Wire
7 weeks ago - Cybin to Participate at the 2024 Milken Institute Future of Health Summit - Business Wire
2 months ago - Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program - Business Wire
2 months ago - Undercovered Dozen: Endava, Cross Country Healthcare, Cybin, Equinor + - Seeking Alpha